Clinical Trial Update: Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis [NA]

View source ↗

Summary

A clinical trial is investigating the pathogenicity of B and CD4 T cell subsets in multiple sclerosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Multiple Sclerosis, Clinically Isolated Syndrome | NA | Status: RECRUITING